NEW YORK, NY / ACCESSWIRE / November 22, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Novo Nordisk for $38.25 per share in cash. If you are a Dicerna shareholder, click here to learn more about your rights and options.
R.R. Donnelley & Sons Company (NYSE:RRD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to affiliates of Atlas Holdings LLC for $8.52 per share in cash.If you are an RRD shareholder, click here to learn more about your rights and options.
Level One Bancorp, Inc. (NASDAQ:LEVL) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to First Merchants Corporation. Under the terms of the merger, Level One shareholders will have the right to receive 0.7167 shares of First Merchants common stock and $10.17 in cash for each share of Level One common stock owned.If you are a Level One shareholder, click here to learn more about your rights and options.
Hill-Rom Holdings, Inc. (NYSE:HRC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Baxter International Inc. for $156.00 per share in cash.If you are a Hill-Rom shareholder, click here to learn more about your rights and options.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
SOURCE: Halper Sadeh LLP
View source version on accesswire.com:
https://www.accesswire.com/674193/SHAREHOLDER-INVESTIGATION-Halper-Sadeh-LLP-Investigates-DRNA-RRD-LEVL-HRC-Shareholders-are-Encouraged-to-Contact-the-Firm
